To include your compound in the COVID-19 Resource Center, submit it here.

Athena, Genica Pharmaceuticals Corp. regulatory update

ATHN (South San Francisco) will acquire privately held Genica for up to 3.5 million shares of ATHN

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE